A Long-term Moderate Intervention With n-3 LC-PUFA-supplemented Dairy Products in Patients With Rheumatoid Arthritis

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Rheumatoid Arthritis
Interventions
DIETARY_SUPPLEMENT

n-3 LC-PUFA

Patients received about 40 g fat daily (200 g yoghurt with 3.8% fat, 30 g cheese with about 50% fat in the dry matter, and 20-30 g butter). The milk fat was partially exchanged by special oils. The daily dose of n-3 FA amounted to 2.4 g, consisting of 1.1 g ALA, 0.7 g EPA, 0.1 g DPA, and 0.4 g DHA.

DIETARY_SUPPLEMENT

Placebo

The placebo products were commercial dairy products with comparable fat contents.

Trial Locations (1)

07743

University of Jena, Institute of Nutrition, Department of Nutritional Physiology, Jena

All Listed Sponsors
lead

University of Jena

OTHER

NCT00638950 - A Long-term Moderate Intervention With n-3 LC-PUFA-supplemented Dairy Products in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter